NCT05793541 Just-in-time Interventions for Reducing Short-term Suicide Risk
| NCT ID | NCT05793541 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Massachusetts General Hospital |
| Condition | Suicide |
| Study Type | INTERVENTIONAL |
| Enrollment | 185 participants |
| Start Date | 2024-11-19 |
| Primary Completion | 2026-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 185 participants in total. It began in 2024-11-19 with a primary completion date of 2026-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this study is to test the effects of just-in-time intervention strategies aimed to promote implementation of the safety plan and its components at different levels of suicidal urges and intent. The main questions the investigators aim to answer are: 1. What is the acceptability and feasibility of the just-in-time intervention strategies? 2. What are the proximal effects of just-in-time intervention strategies aimed to promote use of the safety plan and its components? 3. What internal and external contextual factors moderate the just-in-time intervention effects? Participants (adults hospitalized for suicidal thoughts or behaviors) will: * Answer questions about current suicidal thoughts on their smartphone up to 4 times each day during both hospitalization and the 4 weeks after they leave the hospital * Each time they submit a survey, be immediately randomized to receive (or not receive) a just-in-time intervention tailored to their level of current suicidal thoughts * Answer brief follow-up questions on their smartphone within a couple hours of each randomization * Provide feedback on their experience with the just-in-time interventions
Eligibility Criteria
Inclusion Criteria: * Experiencing suicidal thoughts as part of their inpatient admission * Access to a smartphone following discharge * Ability to speak and write English fluently Exclusion Criteria: * Any factor that impairs the ability to effectively participate in the study (e.g., significant cognitive impairment, intellectual disability, presence of violent behavior, psychotic illness/symptoms determined by the treating clinician to impair ability to understand the study or provide informed consent) * Failure to correctly answer all true/false questions in the consent form
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05793541 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Suicide. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05793541 currently recruiting?
Yes, NCT05793541 is actively recruiting participants. Contact the research team at kbentley@mgh.harvard.edu for enrollment information.
Where is the NCT05793541 trial being conducted?
This trial is being conducted at Boston, United States.
Who is sponsoring the NCT05793541 clinical trial?
NCT05793541 is sponsored by Massachusetts General Hospital. The trial plans to enroll 185 participants.